Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
Cells · 2023
DOI: 10.3390/cells12071071 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Nguyễn Thị Thanh Nhàn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Eye Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH, NEI.
Abstract (Originalsprache)
Cell-penetrating peptides (CPPs) are short peptides with the ability to translocate through the cell membrane to facilitate their cellular uptake. CPPs can be used as drug-delivery systems for molecules that are difficult to uptake. Ocular drug delivery is challenging due to the structural and physiological complexity of the eye. CPPs may be tailored to overcome this challenge, facilitating cellular uptake and delivery to the targeted area. Retinal diseases occur at the posterior pole of the eye; thus, intravitreal injections are needed to deliver drugs at an effective concentration in situ. However, frequent injections have risks of causing vision-threatening complications. Recent investigations have focused on developing long-acting drugs and drug delivery systems to reduce the frequency of injections. In fact, conjugation with CPP could deliver FDA-approved drugs to the back of the eye, as seen by topical application in animal models. This review summarizes recent advances in CPPs, protein/peptide-based drugs for eye diseases, and the use of CPPs for drug delivery based on systematic searches in PubMed and clinical trials. We highlight targeted therapies and explore the potential of CPPs and peptide-based drugs for eye diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA.
- Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, IL 60612, USA.
- Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL 60612, USA.
ORCID-Profile: Daniel E Maidana, Kaori H Yamada
Förderung
- NEI NIH HHS
- NIH
- NEI
Zitieren
APA
Nhàn, N. T. T., Maidana, D. E., & Yamada, K. H. (2023). Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides. Cells. https://doi.org/10.3390/cells12071071
Vancouver
Nhàn NTT, Maidana DE, Yamada KH. Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides. Cells. 2023. doi:10.3390/cells12071071
BibTeX
@article{Nhn2023,
author = {Nhàn, Nguyễn Thị Thanh and Maidana, Daniel E and Yamada, Kaori H},
title = {Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12071071}
}
EUVIMED